Anti-NMDA receptor encephalitis risk factors: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Risk factors for anti-NMDA encephalitis include female predominance, higher incidence in young individuals, and increased likelihood of underlying teratoma in African-Americans and teratomas in Asians. | |||
==Risk Factors== | ==Risk Factors== | ||
Latest revision as of 08:05, 13 May 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis risk factors On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis risk factors |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Overview
Risk factors for anti-NMDA encephalitis include female predominance, higher incidence in young individuals, and increased likelihood of underlying teratoma in African-Americans and teratomas in Asians.
Risk Factors
The risk factors include females preponderance, the high incidence of the disease in youngsters, and the increased likelihood of an underlying teratoma among African-Americans. Asian patients had a higher incidence of teratomas.
References
- ↑ Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T; et al. (2013). "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study". Lancet Neurol. 12 (2): 157–65. doi:10.1016/S1474-4422(12)70310-1. PMC 3563251. PMID 23290630.